Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single Arm Study to Provide Additional Information on Safety and Effectiveness of rVSVΔG-ZEBOV-GP

NCT03161366 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.

NCT NCT03161366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03161366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single Arm Study to Provide Additional Information on Safety and Effectiveness of rVSVΔG-ZEBOV-GP
Lead sponsor
Epicentre
Phase
Phase 3
Overall status
Completed
Start date
May 28, 2018
Completion date
November 30, 2018
Enrollment
500 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ebola virus disease